195 related articles for article (PubMed ID: 38705030)
1. Ferroptosis in antitumor therapy: Unraveling regulatory mechanisms and immunogenic potential.
Zhang T; Zeng X; Zeng E; Wang H
Int Immunopharmacol; 2024 Jun; 134():112203. PubMed ID: 38705030
[TBL] [Abstract][Full Text] [Related]
2. An ultrasound-activated nanoplatform remodels tumor microenvironment through diverse cell death induction for improved immunotherapy.
Ma J; Yuan H; Zhang J; Sun X; Yi L; Li W; Li Z; Fu C; Zheng L; Xu X; Wang X; Wang F; Yin D; Yuan J; Xu C; Li Z; Peng X; Wang J
J Control Release; 2024 Jun; 370():501-515. PubMed ID: 38703950
[TBL] [Abstract][Full Text] [Related]
3. The new era of lung cancer therapy: Combining immunotherapy with ferroptosis.
Li Y; Tuerxun H; Zhao Y; Liu X; Li X; Wen S; Zhao Y
Crit Rev Oncol Hematol; 2024 Jun; 198():104359. PubMed ID: 38615871
[TBL] [Abstract][Full Text] [Related]
4. Iron-based nanoscale coordination polymers synergistically induce immunogenic ferroptosis by blocking dihydrofolate reductase for cancer immunotherapy.
Yu Y; Huang Z; Chen Q; Zhang Z; Jiang H; Gu R; Ding Y; Hu Y
Biomaterials; 2022 Sep; 288():121724. PubMed ID: 36038420
[TBL] [Abstract][Full Text] [Related]
5. Immunogenic ferroptosis and where to find it?
Demuynck R; Efimova I; Naessens F; Krysko DV
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34903554
[TBL] [Abstract][Full Text] [Related]
6. Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity.
Efimova I; Catanzaro E; Van der Meeren L; Turubanova VD; Hammad H; Mishchenko TA; Vedunova MV; Fimognari C; Bachert C; Coppieters F; Lefever S; Skirtach AG; Krysko O; Krysko DV
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33188036
[TBL] [Abstract][Full Text] [Related]
7. Ferroptosis is an effective strategy for cancer therapy.
Khan A; Huo Y; Guo Y; Shi J; Hou Y
Med Oncol; 2024 Apr; 41(5):124. PubMed ID: 38652406
[TBL] [Abstract][Full Text] [Related]
8. Tumor-Targeted Nanomedicine for Immunotherapy.
Cabral H; Kinoh H; Kataoka K
Acc Chem Res; 2020 Dec; 53(12):2765-2776. PubMed ID: 33161717
[TBL] [Abstract][Full Text] [Related]
9. Nanomedicine to aid immunogenic cell death (ICD)-based anticancer therapy.
Demuynck R; Engelen Y; Skirtach AG; De Smedt SC; Lentacker I; Krysko DV
Trends Cancer; 2024 Jun; 10(6):486-489. PubMed ID: 38553361
[TBL] [Abstract][Full Text] [Related]
10. Light-Triggered Nanozymes Remodel the Tumor Hypoxic and Immunosuppressive Microenvironment for Ferroptosis-Enhanced Antitumor Immunity.
Fan Z; Wu S; Deng H; Li G; Huang L; Liu H
ACS Nano; 2024 May; 18(19):12261-12275. PubMed ID: 38683132
[TBL] [Abstract][Full Text] [Related]
11. Ferroptosis, necroptosis, and pyroptosis in anticancer immunity.
Tang R; Xu J; Zhang B; Liu J; Liang C; Hua J; Meng Q; Yu X; Shi S
J Hematol Oncol; 2020 Aug; 13(1):110. PubMed ID: 32778143
[TBL] [Abstract][Full Text] [Related]
12. Ferroptosis in cancer immunity and immunotherapy: Multifaceted interplay and clinical implications.
Zhai X; Lin Y; Zhu L; Wang Y; Zhang J; Liu J; Li L; Lu X
Cytokine Growth Factor Rev; 2024 Feb; 75():101-109. PubMed ID: 37658030
[TBL] [Abstract][Full Text] [Related]
13. Recent progress on targeting ferroptosis for cancer therapy.
Xu G; Wang H; Li X; Huang R; Luo L
Biochem Pharmacol; 2021 Aug; 190():114584. PubMed ID: 33915157
[TBL] [Abstract][Full Text] [Related]
14. Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies.
Zhou Q; Meng Y; Li D; Yao L; Le J; Liu Y; Sun Y; Zeng F; Chen X; Deng G
Signal Transduct Target Ther; 2024 Mar; 9(1):55. PubMed ID: 38453898
[TBL] [Abstract][Full Text] [Related]
15. Deciphering the potential roles of ferroptosis in regulating tumor immunity and tumor immunotherapy.
Gu X; Liu Y; Dai X; Yang YG; Zhang X
Front Immunol; 2023; 14():1137107. PubMed ID: 36926345
[TBL] [Abstract][Full Text] [Related]
16. A nanoformulation for immunosuppression reversal and broad-spectrum self-amplifying antitumor ferroptosis-immunotherapy.
Yang Q; Liu T; Zheng H; Zhou Z; Huang Y; Jia H; Fu S; Zhang X; Zhang H; Liu Y; Chen X; Shan W
Biomaterials; 2023 Jan; 292():121936. PubMed ID: 36502663
[TBL] [Abstract][Full Text] [Related]
17. Ferroptosis Nanomedicine: Clinical Challenges and Opportunities for Modulating Tumor Metabolic and Immunological Landscape.
Yang H; Yao X; Liu Y; Shen X; Li M; Luo Z
ACS Nano; 2023 Aug; 17(16):15328-15353. PubMed ID: 37573530
[TBL] [Abstract][Full Text] [Related]
18. Recent Progress in Ferroptosis Inducers for Cancer Therapy.
Liang C; Zhang X; Yang M; Dong X
Adv Mater; 2019 Dec; 31(51):e1904197. PubMed ID: 31595562
[TBL] [Abstract][Full Text] [Related]
19. Ferroptosis defense mechanisms: The future and hope for treating osteosarcoma.
Ma Y; Cong L; Shen W; Yang C; Ye K
Cell Biochem Funct; 2024 Jun; 42(4):e4080. PubMed ID: 38924104
[TBL] [Abstract][Full Text] [Related]
20. Inflammation-related pyroptosis, a novel programmed cell death pathway, and its crosstalk with immune therapy in cancer treatment.
Hsu SK; Li CY; Lin IL; Syue WJ; Chen YF; Cheng KC; Teng YN; Lin YH; Yen CH; Chiu CC
Theranostics; 2021; 11(18):8813-8835. PubMed ID: 34522213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]